Literature DB >> 7991570

Bone marrow declines as a site of B-cell precursor differentiation with age: relationship to thymus involution.

A Ben-Yehuda1, P Szabo, R Dyall, M E Weksler.   

Abstract

The rearrangement of immunoglobulin genes in B-lymphocyte precursors requires the expression of the recombination activating genes (Rag), which leads to the generation of a highly diverse B-cell repertoire. We can use the level of Rag-1 mRNA in the bone marrow as an index of its capacity to support the maturation of B lymphocytes as all detectable bone marrow Rag-1 mRNA is expressed by B-cell precursors. In mouse bone marrow, Rag-1 mRNA increases during the first 2 months of life to reach its maximal level at 2 months of age. This level is maintained until 5 months of age and thereafter declines to a minimum level by 10 months of age. Thus, bone marrow Rag-1 mRNA is highest at the time when thymic function is maximal in euthymic mice. An association between thymic activity and bone marrow Rag-1 gene expression was supported by showing a low level of bone marrow Rag-1 mRNA in athymic nude mice at an age when this gene is maximally expressed in euthymic mice. Another characteristic of B cells in nude mice is their preferential rearrangement of diversity region (D)-proximal heavy-chain variable region (VH) genes. We demonstrated that injection of syngeneic splenic T cells into nude mice not only stimulates an increase in Rag-1 mRNA in their bone marrow B-cell precursors but also restores their random use of VH genes. Most interestingly, injection of supernatant medium from phytohemagglutinin-activated splenic T-cell cultures from young euthymic mice also induces both Rag-1 mRNA in bone marrow B-cell precursors and random use of VH genes. These findings suggest that thymic function can regulate both Rag-1 gene expression and VH gene use by bone marrow B-cell precursors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7991570      PMCID: PMC45361          DOI: 10.1073/pnas.91.25.11988

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

Review 1.  Molecular and cellular origins of B lymphocyte diversity.

Authors:  A Rolink; F Melchers
Journal:  Cell       Date:  1991-09-20       Impact factor: 41.582

2.  RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination.

Authors:  M A Oettinger; D G Schatz; C Gorka; D Baltimore
Journal:  Science       Date:  1990-06-22       Impact factor: 47.728

3.  Stimulation of B-cell progenitors by cloned murine interleukin-7.

Authors:  A E Namen; S Lupton; K Hjerrild; J Wignall; D Y Mochizuki; A Schmierer; B Mosley; C J March; D Urdal; S Gillis
Journal:  Nature       Date:  1988-06-09       Impact factor: 49.962

4.  VH-gene family dominance in ageing mice.

Authors:  A C Viale; J A Chies; F Huetz; E Malenchere; M Weksler; A A Freitas; A Coutinho
Journal:  Scand J Immunol       Date:  1994-02       Impact factor: 3.487

Review 5.  Somatic generation of antibody diversity.

Authors:  S Tonegawa
Journal:  Nature       Date:  1983-04-14       Impact factor: 49.962

6.  The V(D)J recombination activating gene, RAG-1.

Authors:  D G Schatz; M A Oettinger; D Baltimore
Journal:  Cell       Date:  1989-12-22       Impact factor: 41.582

7.  RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement.

Authors:  Y Shinkai; G Rathbun; K P Lam; E M Oltz; V Stewart; M Mendelsohn; J Charron; M Datta; F Young; A M Stall
Journal:  Cell       Date:  1992-03-06       Impact factor: 41.582

8.  The recombination activating gene-1 (RAG-1) transcript is present in the murine central nervous system.

Authors:  J J Chun; D G Schatz; M A Oettinger; R Jaenisch; D Baltimore
Journal:  Cell       Date:  1991-01-11       Impact factor: 41.582

9.  Selection of antibody repertories: transfer of mature T lymphocytes modifies VH gene family usage in the actual and available B cell repertories of athymic mice.

Authors:  A A Freitas; M P Lembezat; B Rocha
Journal:  Int Immunol       Date:  1989       Impact factor: 4.823

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  8 in total

1.  Age-dependent altered proportions in subpopulations of tonsillar lymphocytes.

Authors:  W Bergler; S Adam; H J Gross; K Hörmann; R Schwartz-Albiez
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

Review 2.  Role of allergen sensitization in older adults.

Authors:  Ravi K Viswanathan; Sameer K Mathur
Journal:  Curr Allergy Asthma Rep       Date:  2011-10       Impact factor: 4.806

3.  Age-related autoantibody production in a nonhuman primate model.

Authors:  R Attanasio; K M Brasky; S H Robbins; L Jayashankar; R J Nash; T M Butler
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

Review 4.  Immunodeficiency of aging.

Authors:  E A Burns; J S Goodwin
Journal:  Drugs Aging       Date:  1997-11       Impact factor: 4.271

Review 5.  The effect of age on the B-cell repertoire.

Authors:  M E Weksler; P Szabo
Journal:  J Clin Immunol       Date:  2000-07       Impact factor: 8.542

6.  Myc-Interacting Zinc Finger Protein 1 (Miz-1) Is Essential to Maintain Homeostasis and Immunocompetence of the B Cell Lineage.

Authors:  Eva-Maria Piskor; Julie Ross; Tarik Möröy; Christian Kosan
Journal:  Biology (Basel)       Date:  2022-03-24

Review 7.  Immunosupportive therapies in aging.

Authors:  Tamas Fülöp; Anis Larbi; Katsuiku Hirokawa; Eugenio Mocchegiani; Bruno Lesourds; Stephen Castle; Anders Wikby; Claudio Franceschi; Graham Pawelec
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

8.  Bone marrow microenvironmental changes underlie reduced RAG-mediated recombination and B cell generation in aged mice.

Authors:  Joseph E Labrie; Alex P Sah; David M Allman; Michael P Cancro; Rachel M Gerstein
Journal:  J Exp Med       Date:  2004-08-16       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.